A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said ...

BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, ...

In mCRPC patients with BRCA1/2 or ATM alterations, first-line treatment with abiraterone plus prednisone and olaparib improves OS.

An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...

The first-line combination of olaparib (Lynparza) plus abiraterone (Zytiga) led to a significant overall survival (OS) advantage for patients with metastatic castration-resistant prostate cancer ...

Dana Soday marked two years of cancer treatment Wednesday with her final infusion at the Ochsner Cancer Center — and a declaration that she is cancer-free.

FDA fast track covers ART6043 plus olaparib in PARP inhibitor–naïve gBRCAm, HER2-negative locally advanced/metastatic breast ...

"Reassuring" data show more breast cancers with surveillance, but no difference in surviva ...

Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...

There is no single “right” approach to genetic testing. It’s a personal decision, and what works for me may not work for ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

For most of my life, I thought cancer prevention for men was straightforward: don’t smoke, eat a healthy diet, exercise, manage stress and get regular medical checkups.